BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 15328108)

  • 41. In vivo bioluminescence imaging for the study of intestinal colonization by Escherichia coli in mice.
    Foucault ML; Thomas L; Goussard S; Branchini BR; Grillot-Courvalin C
    Appl Environ Microbiol; 2010 Jan; 76(1):264-74. PubMed ID: 19880653
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Decomposition of sulfamethoxazole and trimethoprim by continuous UVA/LED/TiO
    Cai Q; Hu J
    J Hazard Mater; 2017 Feb; 323(Pt A):527-536. PubMed ID: 27324695
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vivo bioluminescent imaging of a new model of infectious complications in head-injury rats.
    Moinard C; Butel MJ; Bureau MF; Choisy C; Waligora-Dupriet AJ; Moulis J; Marc J; Cynober L; Charrueau C
    J Neurotrauma; 2012 Jan; 29(2):335-42. PubMed ID: 21806472
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of Highly Virulent Extraintestinal Pathogenic Escherichia coli Pneumonia With Bacteriophages.
    Dufour N; Debarbieux L; Fromentin M; Ricard JD
    Crit Care Med; 2015 Jun; 43(6):e190-8. PubMed ID: 25803649
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transformation of serum-susceptible Escherichia coli O111 with p16Slux plasmid to allow for real-time monitoring of complement-based inactivation of bacterial growth in bovine milk.
    Maye S; Stanton C; Fitzgerald GF; Kelly PM
    J Dairy Sci; 2016 Jan; 99(1):112-9. PubMed ID: 26585477
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Escherichia coli K-12 (pEGFPluxABCDEamp): a tool for analysis of bacterial killing by antibacterial agents and human complement activities on a real-time basis.
    Atosuo J; Lehtinen J; Vojtek L; Lilius EM
    Luminescence; 2013; 28(5):771-9. PubMed ID: 23129448
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Construction of a bioluminescent mycobacterium and its use for assay of antimycobacterial agents.
    Andrew PW; Roberts IS
    J Clin Microbiol; 1993 Sep; 31(9):2251-4. PubMed ID: 8408541
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Generation of bioluminescent Streptococcus mutans and its usage in rapid analysis of the efficacy of antimicrobial compounds.
    Loimaranta V; Tenovuo J; Koivisto L; Karp M
    Antimicrob Agents Chemother; 1998 Aug; 42(8):1906-10. PubMed ID: 9687382
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Rapid bioluminescent antibiotic susceptibility assay].
    Frundzhian VG; Ugarova NN; Blatun LA; Terekhova RP; Rusanova EV
    Antibiot Khimioter; 2009; 54(7-8):8-12. PubMed ID: 20201396
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Monitoring photodynamic therapy of localized infections by bioluminescence imaging of genetically engineered bacteria.
    Demidova TN; Gad F; Zahra T; Francis KP; Hamblin MR
    J Photochem Photobiol B; 2005 Oct; 81(1):15-25. PubMed ID: 16040251
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A correlation with type of sulfonamide resistance gene in Escherichia coli and synergy between trimethoprim and sulfamethoxazole.
    Valentine CR; Hawk JM; Christian MM; Youmans RW
    J Basic Microbiol; 1992; 32(3):201-7. PubMed ID: 1512711
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative efficacies of antibiotics in a rat model of meningoencephalitis due to Listeria monocytogenes.
    Michelet C; Leib SL; Bentue-Ferrer D; Täuber MG
    Antimicrob Agents Chemother; 1999 Jul; 43(7):1651-6. PubMed ID: 10390217
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of a biosensor for on-line detection of tributyltin with a recombinant bioluminescent Escherichia coli strain.
    Thouand G; Horry H; Durand MJ; Picart P; Bendriaa L; Daniel P; DuBow MS
    Appl Microbiol Biotechnol; 2003 Aug; 62(2-3):218-25. PubMed ID: 12883867
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Generation of Bioluminescent Group A Streptococcus for Biophotonic Imaging.
    Loh JMS; Soh KY; Proft T
    Methods Mol Biol; 2020; 2136():71-77. PubMed ID: 32430814
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rapid antibiotic susceptibility testing in a microfluidic pH sensor.
    Tang Y; Zhen L; Liu J; Wu J
    Anal Chem; 2013 Mar; 85(5):2787-94. PubMed ID: 23360389
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vivo bioluminescence imaging for early detection and monitoring of disease progression in a murine model of neuroblastoma.
    Dickson PV; Hamner B; Ng CY; Hall MM; Zhou J; Hargrove PW; McCarville MB; Davidoff AM
    J Pediatr Surg; 2007 Jul; 42(7):1172-9. PubMed ID: 17618876
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A recombinant Escherichia coli sensor strain for the detection of tetracyclines.
    Korpela MT; Kurittu JS; Karvinen JT; Karp MT
    Anal Chem; 1998 Nov; 70(21):4457-62. PubMed ID: 9823708
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In Vivo Bioluminescence Imaging of Intratumoral Bacteria.
    Cronin M; Akin AR; Francis KP; Tangney M
    Methods Mol Biol; 2016; 1409():69-77. PubMed ID: 26846803
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bioluminescent imaging of bacteria during mouse infection.
    Warawa JM; Lawrenz MB
    Methods Mol Biol; 2014; 1098():169-81. PubMed ID: 24166377
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Definitions of antibacterial interactions in animal infection models.
    Renneberg J
    J Antimicrob Chemother; 1993 May; 31 Suppl D():167-75. PubMed ID: 8335518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.